Dose-dependent targeting of 89Zr-labeled atezolizumab (anti-PD-L1 antibody) to PD-L1 expressing tumor xenografts

被引：0
|
作者：
Longtine, Mark [1 ]
Wahl, Richard [1 ]
机构：
[1] Mallinckrodt Inst Radiol, St Louis, MO USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2018年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1105
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Malignant Mesothelioma Effusions Are Infiltrated by CD3+ T Cells Highly Expressing PD-L1 and the PD-L1+ Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti-PD-L1 Antibody Avelumab
    Khanna, Swati
    Thomas, Anish
    Abate-Daga, Daniel
    Zhang, Jingli
    Morrow, Betsy
    Steinberg, Seth M.
    Orlandi, Augusto
    Ferroni, Patrizia
    Schlom, Jeffrey
    Guadagni, Fiorella
    Hassan, Raffit
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : 1993 - 2005
  • [32] Macrophages are important source of PD-L1 and PD-L1 expressing in macrophages affect the prognosis of NSCLC patients with tumor PD-L1 negative
    Liu, Y.
    Cao, L.
    Che, X.
    Qiu, X.
    Li, Z.
    Yang, B.
    Wang, S.
    Qu, X.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 531 - 532
  • [33] HMGB1 assists the predictive value of tumor PD-L1 expression for the efficacy of anti-PD-1/PD-L1 antibody in NSCLC
    Funaishi, Kunihiko
    Yamaguchi, Kakuhiro
    Tanahashi, Hiroki
    Kurose, Koji
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Nakashima, Taku
    Iwamoto, Hiroshi
    Hamada, Hironobu
    Oga, Toru
    Oka, Mikio
    Hattori, Noboru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
  • [34] Immuno-PET using Zirconium-89 (89Zr) radiolabeled fully human anti-PD-L1 antibody successfully images PD-L1 positive tumors in preclinical mouse models
    Kelly, Marcus
    Giurleo, Jason
    Makonnen, Sosina
    Hickey, Carlos
    Arnold, T. Cody
    Ma, Dangshe
    Dai, Jie
    Pei, Jerry
    Tavare, Richard
    Kirshner, Jessica
    Olson, William
    Thurston, Gavin
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [35] Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
    Li, Maohua
    Zhao, Rongqing
    Chen, Jianxin
    Tian, Wenzhi
    Xia, Chenxi
    Liu, Xudong
    Li, Yingzi
    Li, Song
    Sun, Hunter
    Shen, Tong
    Ren, Wenlin
    Sun, Le
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [36] Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
    Maohua Li
    Rongqing Zhao
    Jianxin Chen
    Wenzhi Tian
    Chenxi Xia
    Xudong Liu
    Yingzi Li
    Song Li
    Hunter Sun
    Tong Shen
    Wenlin Ren
    Le Sun
    Scientific Reports, 11
  • [37] PET imaging of radiation-induced PD-L1 upregulation in the tumor microenvironment using a Zr-89 labeled PD-L1 monoclonal Ab in a mouse model
    Kikuchi, Masahiro
    Srivastava, Raghvendra
    Sun, Lingyi
    Zeng, Dexing
    Diaz-Perez, Julio
    Anderson, Carolyn
    Ferris, Robert
    Edwards, W. Barry
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [38] Dynamic changes of plasma PD-L1 mRNA expression is associated with anti-PD-1/anti-PD-L1 response in malignancies
    Yang, Q.
    Chen, M.
    Gu, J.
    Zheng, L.
    Yu, Y.
    Li, F.
    Zhang, L.
    Niu, K.
    Sun, J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1777 - 1778
  • [39] VENTANA anti-PD-L1 (SP263) rabbit monoclonal antibody: A high specificity and sensitivity anti-human PD-L1 antibody
    Quon, Chenglu
    Xia, Xiaoling
    Smith, Margaret
    Drace, Colene
    Mistry, Amita
    Nielsen, Alma
    Sabalos, Costi
    Towne, Penny
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Benefit with anti-PD-L1
    Diana Romero
    Nature Reviews Clinical Oncology, 2017, 14 : 71 - 71
12345